DiRaimondo Thomas
- SEC CIK
- 0002005618
In the past year, 1 open-market sale filing worth $34.4K and no purchases.
Current role at each company
- JANX Janux Therapeutics, Inc.Chief Scientific Officeras of Jan 2, 2026
Open-market trades in the past year
Open-market purchases (P) and sales (S) filed in the last 365 days, not counting derivative securities or duplicate filings. Values leave out price outliers.
- Bought
- –
- 0 filings
- Sold
- $34.4K
- 1 filing
- Net
- −$34.4K
- Bought minus sold
- Companies
- 1
- With open-market trades
Trades
Every Form 4 that lists DiRaimondo Thomas as a reporting owner, including filings made jointly with others, grouped by company. Each row adds up one type of transaction in one filing. Only open-market purchases (P) and sales (S) are shown by default.
| Filed (ET) | Trade date | Filing delay | Insider | Transaction | Shares | Avg price | Value | Holding change | Flags |
|---|---|---|---|---|---|---|---|---|---|
| Jan 2, 2026 (view filing) | Jan 2 | Same day | DiRaimondo ThomasChief Scientific Officer | SSale | −2.50K | $13.73 | −$34.4K | −2.0%124.4K after | |
| Sep 27, 2024 (view filing) | Sep 27 | Same day | DiRaimondo ThomasChief Scientific Officer | SSale | −5.00K | $46.35 | −$231.7K | −4.9%97.9K after | 2 lots10b5-1 |